Home › Funds › Tetragon Partners GP Ltd › TENX
Tetragon Partners GP Ltd position in TENX
TENAX THERAPEUTICS INC · Health Care
Tetragon Partners GP Ltd reported holding 75,100 shares of TENX (TENAX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$142K, representing 0.02% of its reported portfolio and ranking #34 among its reported holdings. Tetragon Partners GP Ltd has disclosed TENX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Tetragon Partners GP Ltd's TENX position evolved
Tetragon Partners GP Ltd first disclosed a stake in TENX in Q2 2026 at 75,100 shares (US$1.1M). Across 2 filings, Tetragon Partners GP Ltd held the position steady without any share-count change. The most recent filing (Q3 2026) shows 75,100 shares valued at US$142K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 75.10K | $1.09M | New |
| Q3 2026 | 75.10K | $141.94K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TENX and 13F data
TENX (TENAX THERAPEUTICS INC) is a Health Care company. 56 other funds we track also report a position in TENX — the largest reported positions include ADAR1 Capital Management, LLC (US$12.3M), BVF INC/IL (US$4.9M), Vivo Capital, LLC (US$4.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TENX
- ADAR1 Capital Management, LLC 6.52M sh · $12.33M · Q3 2026
- BVF INC/IL 339.55K sh · $4.94M · Q2 2026
- Vivo Capital, LLC 2.50M sh · $4.72M · Q3 2026
- Avidity Partners Management LP 265.93K sh · $3.87M · Q2 2026
- Stonepine Capital Management, LLC 588.00K sh · $1.11M · Q3 2026
- Jones Hill Capital LP 122.17K sh · $230.90K · Q3 2026
More on Tetragon Partners GP Ltd
FAQ
How long has Tetragon Partners GP Ltd held TENX?
Tetragon Partners GP Ltd has disclosed TENX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Tetragon Partners GP Ltd's current position in TENX?
As of Q3 2026, Tetragon Partners GP Ltd holds 75.10K shares of TENX (TENAX THERAPEUTICS INC), valued at $141.94K, representing 0.02% of its reported portfolio and ranking #34.
Has Tetragon Partners GP Ltd been buying or selling TENX?
In the latest 13F filing (Q3 2026), Tetragon Partners GP Ltd held unchanged its position in TENX.
Which other funds hold TENX?
Other major institutional holders of TENX include ADAR1 Capital Management, LLC, BVF INC/IL, Vivo Capital, LLC, among 56 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.